WHO ICTRP trial
Phase II study of micafungin as empirical antifungal therapy for febrile…
JPRN-C000000382 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-C000000382 |
|---|---|
| Public title | Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study) |
| Scientific title | Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study) - Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study) |
| Primary sponsor | Center for Supporting Hematology-Oncology Trials (C-SHOT) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Febrile neutropenia |
| Interventions | Micafungin intravenously over 1 hour at a daily dose of 150 mg |
| Registration date | Mar 30, 2006 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: